LRN vs UTI

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 30, 2026

LRN

54.5
AI Score
VS
LRN Wins

UTI

39.8
AI Score

Investment Advisor Scores

LRN

55score
Recommendation
HOLD

UTI

40score
Recommendation
AVOID NEW MONEY

AI Analyst Insights

Detailed Metrics Comparison

Metric LRN UTI Winner
Forward P/E 8.5616 27.248 LRN
PEG Ratio 0.4282 1.8142 LRN
Revenue Growth -2.7% 7.2% UTI
Earnings Growth 69.6% -78.9% LRN
Tradestie Score 54.5/100 39.8/100 LRN
Profit Margin 13.4% 3.9% LRN
Beta 1.00 1.00 Tie
AI Recommendation HOLD AVOID NEW MONEY LRN

Relative Price Performance (Last 90 Days)

LRN 1M: -11.2% · 3M: -14.3% UTI 1M: -8.7% · 3M: -60.6%

Current Technical Phase

LRN

Markdown
Sell / avoid

Price below a falling SMA50 (slope -3.4%), weak momentum, RSI 40

RSI (14): 40.0 · Price: $77.52

UTI

Markdown
Sell / avoid

Price below a falling SMA50 (slope -26.6%), weak momentum, RSI 32

RSI (14): 31.7 · Price: $19.03

Fundamentals Snapshot

Metric LRN UTI
Market Cap — —
Forward P/E 8.9 25.9
Trailing P/E 10.6 30.6
Revenue (TTM) — —
Revenue Growth 0.0% 0.1%
Gross Margin 0.4% 0.6%
Operating Margin 0.2% 0.0%
EPS 7.37 0.61
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, LRN is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.